Indicative Pricing for Retail Bond Offer

NZX MEDIA RELEASE 7 December 2020 RYMAN ANNOUNCES INDICATIVE PRICING FOR RETAIL BOND OFFER Further to the announcement by Ryman Healthcare Limited (Ryman) of an offer of up to $100 million (with the ability to accept oversubscriptions of up to an additional $50 million at Ryman's discretion) of 6 year, secured fixed rate bonds maturing on 18 December 2026, Ryman today announced indicative pricing for the offer. The indicative issue margin range is 2.00% to 2.20% per annum over the underlying swap rate, subject to a minimum interest rate of 2.50% per annum. The actual issue margin may be above or below the indicative issue margin range. The issue margin and interest rate will be set following a bookbuild process on 10 December 2020 and will be announced by Ryman via NZX shortly thereafter. The offer opens today and will close on 10 December 2020 following the bookbuild process, with the bonds expected to be issued on 18 December 2020. Full details of the bond offer are contained in the Product Disclosure Statement (PDS). The PDS is available through www.rymanhealthcare.co.nz/investors/bonds or by contacting the Joint Lead Managers or your usual financial adviser, and must be obtained by investors before they decide to acquire any bonds. Ryman has applied for the bonds to be quoted on the NZX Debt Market. There is no public pool for the bonds, with all of the bonds being reserved for the Joint Lead Managers, NZX participants and other approved financial intermediaries invited to participate in the bookbuild. A copy of the indicative terms sheet is attached, and available through www.rymanhealthcare.co.nz/investors/bonds. Joint Lead Managers ANZ 0800 269 476 Forsyth Barr 0800 367 227 Hobson Wealth 0800 742 737 Westpac 0800 942 822 About Ryman: Ryman Healthcare was founded in Christchurch in 1984 and owns and operates 39 retirement villages in New Zealand and Australia. Ryman villages are home to more than 12,000 residents, and the group employs more than 6,000 staff. Contacts: For investor relations information contact Michelle Perkins, Investor Relations Manager, on 027 222 9684 (+64 27 222 9684) or email michelle.perkins@rymanhealthcare.com For media information or images contact David King, Corporate Affairs Manager, on 021 499 602 (+64 21 499 602) or email david.king@rymanhealthcare.com End CA:00364533 For:RYM Type:OFFER Time:2020-12-07 08:31:08